ATE237343T1 - Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik - Google Patents

Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik

Info

Publication number
ATE237343T1
ATE237343T1 AT95912306T AT95912306T ATE237343T1 AT E237343 T1 ATE237343 T1 AT E237343T1 AT 95912306 T AT95912306 T AT 95912306T AT 95912306 T AT95912306 T AT 95912306T AT E237343 T1 ATE237343 T1 AT E237343T1
Authority
AT
Austria
Prior art keywords
retropeptides
vaccination
antibodies against
vitro diagnostics
antibodies
Prior art date
Application number
AT95912306T
Other languages
English (en)
Inventor
Gilles Guichard
Sylviane Muller
Jean-Paul Briand
Marc Regenmortel
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE237343T1 publication Critical patent/ATE237343T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT95912306T 1994-03-14 1995-03-13 Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik ATE237343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402950A FR2717081B1 (fr) 1994-03-14 1994-03-14 Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
PCT/FR1995/000292 WO1995024916A1 (fr) 1994-03-14 1995-03-13 RETROPEPTIDES, ANTICORPS DIRIGES CONTRE CES DERNIERS, ET LEURS UTILISATIONS POUR LA VACCINATION ET LE DIAGNOSTIC $i(IN VITRO)

Publications (1)

Publication Number Publication Date
ATE237343T1 true ATE237343T1 (de) 2003-05-15

Family

ID=9461014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95912306T ATE237343T1 (de) 1994-03-14 1995-03-13 Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik

Country Status (6)

Country Link
US (2) US6455244B1 (de)
EP (1) EP0750508B1 (de)
AT (1) ATE237343T1 (de)
DE (1) DE69530380T2 (de)
FR (1) FR2717081B1 (de)
WO (1) WO1995024916A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717081B1 (fr) 1994-03-14 1996-06-21 Centre Nat Rech Scient Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
AU5269800A (en) * 1999-05-14 2000-12-05 Arbor Vita Corporation Molecular interactions in allergy cells
US20050084908A1 (en) * 2000-11-06 2005-04-21 Chugai Seiyaku Kabushiki Kaisha Methods for detecting binding of low-molecular-weight compound and its binding partner molecule
CA2478547C (en) * 2001-12-03 2011-09-20 Abgenix, Inc. Identification of high affinity molecules by limited dilution screening
JP2005512043A (ja) * 2001-12-03 2005-04-28 アブジェニックス・インコーポレーテッド 治療剤産物の発見
AU2002357060A1 (en) 2001-12-03 2003-06-17 Abgenix, Inc. Antibody categorization based on binding characteristics
AU2003286729A1 (en) * 2002-10-25 2004-05-13 University Of Massachusetts Modulation of cellular proliferation
CA2632714A1 (en) * 2005-12-07 2007-06-14 Technische Universitaet Muenchen Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
ZA200805602B (en) 2006-01-17 2009-12-30 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein E; pE)
US7857801B2 (en) 2007-03-23 2010-12-28 The Procter & Gamble Company Diaper having deployable chassis ears and stretch waistband
CN102621315B (zh) * 2011-01-28 2014-06-11 上海科新生物技术股份有限公司 胶体金层析法抗Ro52抗体检测试纸及其制备方法
RU2732010C1 (ru) * 2020-03-11 2020-09-10 Федеральное бюджетное учреждение науки "Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. академика И.Н. Блохиной" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ прогнозирования тяжести течения ВЭБ-ассоциированного инфекционного мононуклеоза

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
FR2648045B1 (fr) * 1989-06-13 1991-09-27 Centre Nat Rech Scient Composes oligonucleotidiques anomeres alpha inhibant la replication des retrovirus
AU648140B2 (en) 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
AU1194092A (en) 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US5763408A (en) 1992-06-03 1998-06-09 Fuji Photo Film Co., Ltd. Amino acid derivatives and application thereof
HUT71860A (en) * 1992-08-27 1996-02-28 Deakin Res Ltd Retro-, inverso-, and retro-inverso synthetic peptide analogues
FR2717081B1 (fr) 1994-03-14 1996-06-21 Centre Nat Rech Scient Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.

Also Published As

Publication number Publication date
EP0750508B1 (de) 2003-04-16
US7122193B1 (en) 2006-10-17
DE69530380T2 (de) 2003-11-27
FR2717081B1 (fr) 1996-06-21
WO1995024916A1 (fr) 1995-09-21
FR2717081A1 (fr) 1995-09-15
US6455244B1 (en) 2002-09-24
EP0750508A1 (de) 1997-01-02
DE69530380D1 (de) 2003-05-22

Similar Documents

Publication Publication Date Title
ATE237343T1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
BR0113822A (pt) Vacina
IT7822237A0 (it) Eccipiente per uso nella preparazione di prodotti farmaceutici allo stato solido.
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
ATE216590T1 (de) Arzneimittelformulierungen für il-12
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
IT8419308A0 (it) Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico.
AU9363398A (en) Hepatitis c receptor protein cd81
IT1270618B (it) Proteine ad attivita' antitumorale
HUP0204216A2 (en) A new use of antibodies as vaccines
ATE254137T1 (de) ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
ATE17652T1 (de) L-alanyl-d-isoglutaminyl-adamantylamid, verfahren zu seiner herstellung und pharmazeutische mittel mit dieser verbindung.
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
EA199800368A1 (ru) Новые промежуточные продукты и их использование для получения n,n'-мостиковых бисиндолилмалеимидов
ES2194008T3 (es) Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties